These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 3607752

  • 1. Preparation of drug-low density lipoprotein complexes for delivery of antitumoral drugs via the low density lipoprotein pathway.
    Lundberg B.
    Cancer Res; 1987 Aug 01; 47(15):4105-8. PubMed ID: 3607752
    [Abstract] [Full Text] [Related]

  • 2. Uptake of low-density lipoprotein by malignant cells--possible therapeutic applications.
    Vitols S.
    Cancer Cells; 1991 Dec 01; 3(12):488-95. PubMed ID: 1840290
    [Abstract] [Full Text] [Related]

  • 3. Low-density lipoprotein for delivery of an acrylophenone antineoplastic molecule into malignant cells.
    Lestavel-Delattre S, Martin-Nizard F, Clavey V, Testard P, Favre G, Doualin G, Houssaini HS, Bard JM, Duriez P, Delbart C.
    Cancer Res; 1992 Jul 01; 52(13):3629-35. PubMed ID: 1617635
    [Abstract] [Full Text] [Related]

  • 4. Low density lipoprotein and liposome mediated uptake and cytotoxic effect of N4-octadecyl-1-beta-D-arabinofuranosylcytosine in Daudi lymphoma cells.
    Koller-Lucae SK, Schott H, Schwendener RA.
    Br J Cancer; 1999 Jul 01; 80(10):1542-9. PubMed ID: 10408395
    [Abstract] [Full Text] [Related]

  • 5. [Targeting of tumor cells by low density lipoproteins: principle and use of ellipticin derivatives].
    Favre G.
    C R Seances Soc Biol Fil; 1992 Jul 01; 186(1-2):73-87. PubMed ID: 1450992
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Low-density lipoprotein as a carrier of antitumoral drugs: in vivo fate of drug-human low-density lipoprotein complexes in mice.
    Masquelier M, Vitols S, Peterson C.
    Cancer Res; 1986 Aug 01; 46(8):3842-7. PubMed ID: 3731059
    [Abstract] [Full Text] [Related]

  • 8. Modulation of low density lipoprotein receptor activity in squamous carcinoma cells by variation in cell density.
    Vermeer BJ, Wijsman MC, Mommaas-Kienhuis AM, Ponec M, Havekes L.
    Eur J Cell Biol; 1985 Sep 01; 38(2):353-60. PubMed ID: 3899647
    [Abstract] [Full Text] [Related]

  • 9. Cytotoxic effect of a lipophilic alkylating agent after incorporation into low density lipoprotein or emulsions: studies in human leukemic cells.
    Masquelier M, Lundberg B, Peterson C, Vitols S.
    Leuk Res; 2006 Feb 01; 30(2):136-44. PubMed ID: 16085310
    [Abstract] [Full Text] [Related]

  • 10. [Vectorization of antineoplastic drugs by low density lipoproteins: incorporation of acyl celiptium and metabolism of complexes in the cellular receptor of human fibroblasts].
    Samadi-Baboli M, Favre G, Soula G.
    Bull Cancer; 1989 Feb 01; 76(8):853-7. PubMed ID: 2620112
    [No Abstract] [Full Text] [Related]

  • 11. Cytotoxic activity of two new lipophilic steroid nitrogen carbamates incorporated into low-density lipoprotein.
    Lundberg B.
    Anticancer Drug Des; 1994 Oct 01; 9(5):471-6. PubMed ID: 7945729
    [Abstract] [Full Text] [Related]

  • 12. Native and acetylated low density lipoprotein metabolism in proliferating and quiescent bovine endothelial cells in culture.
    Sanan DA, Strümpfer AE, van der Westhuyzen DR, Coetzee GA.
    Eur J Cell Biol; 1985 Jan 01; 36(1):81-90. PubMed ID: 3979404
    [Abstract] [Full Text] [Related]

  • 13. Bunazosin enhances receptor-mediated endocytosis of low-density lipoproteins.
    Matsunaga A, Hidaka K, Sasaki J, Arakawa K.
    Artery; 1992 Jan 01; 19(6):307-17. PubMed ID: 1361724
    [Abstract] [Full Text] [Related]

  • 14. Prolonged serum half-life of antineoplastic drugs by incorporation into the low density lipoprotein.
    de Smidt PC, van Berkel TJ.
    Cancer Res; 1990 Dec 01; 50(23):7476-82. PubMed ID: 2147578
    [Abstract] [Full Text] [Related]

  • 15. Heparan sulfate proteoglycan-mediated uptake of apolipoprotein E-triglyceride-rich lipoprotein particles: a major pathway at physiological particle concentrations.
    Al-Haideri M, Goldberg IJ, Galeano NF, Gleeson A, Vogel T, Gorecki M, Sturley SL, Deckelbaum RJ.
    Biochemistry; 1997 Oct 21; 36(42):12766-72. PubMed ID: 9335533
    [Abstract] [Full Text] [Related]

  • 16. Synthetic nano-LDL with paclitaxel oleate as a targeted drug delivery vehicle for glioblastoma multiforme.
    Nikanjam M, Gibbs AR, Hunt CA, Budinger TF, Forte TM.
    J Control Release; 2007 Dec 20; 124(3):163-71. PubMed ID: 17964677
    [Abstract] [Full Text] [Related]

  • 17. [The cytotoxic effect of a low density lipoprotein delivered aclarubicin on leukemia cells].
    Li W, Xi S, Zhang M.
    Zhonghua Xue Ye Xue Za Zhi; 2001 Dec 20; 22(12):636-8. PubMed ID: 16200711
    [Abstract] [Full Text] [Related]

  • 18. The betaA4 amyloid peptide complexes to and enhances the uptake of beta-very low density lipoproteins by the low density lipoprotein receptor-related protein and heparan sulfate proteoglycans pathway.
    Scharnagl H, Tisljar U, Winkler K, Hüttinger M, Nauck MA, Gross W, Wieland H, Ohm TG, März W.
    Lab Invest; 1999 Oct 20; 79(10):1271-86. PubMed ID: 10532590
    [Abstract] [Full Text] [Related]

  • 19. Preparation of anti-HIV-low-density lipoprotein complexes for delivery of anti-HIV drugs via the low-density lipoprotein pathways.
    Sqalli-Houssaini H, Pierlot C, Kusnierz JP, Parmentier B, Martin-Nizard F, Lestavel-Delattre S, Tartar A, Fruchart JC, Sergheraert C, Duriez P.
    Biotechnol Ther; 1994 Oct 20; 5(1-2):69-85. PubMed ID: 7703834
    [Abstract] [Full Text] [Related]

  • 20. Metabolism of native and naturally occurring multiple modified low density lipoprotein in smooth muscle cells of human aortic intima.
    Tertov VV, Orekhov AN.
    Exp Mol Pathol; 1997 Oct 20; 64(3):127-45. PubMed ID: 9439479
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.